Skip to main content
Caplight Logo









Suzhou Inhal Pharma Co., Ltd.

Suzhou Inhal Pharma Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttps://www.inhalpharma.com/

Last Round

Series B

Dec 31, 2025

Total Funding Raised

$27.5M

Company Overview

Suzhou Inhal Pharma Co., Ltd. is a pharmaceutical technology company that specializes in the research and development of inhalation formulations, inhalers, and filling equipment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

dry powder inhalationDPIdrug-device combinationpulmonary drug deliveryinhalation deviceprecision filling equipmentinhaler manufacturingbiotech R&D servicesmicro-dosing systemsrespiratory drug deliveryinhalation formulationCDMOdrug delivery platforminhalation flow monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Inhal Pharma Co., Ltd. Comparables

Compare Suzhou Inhal Pharma Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou Inhal Pharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Suzhou Singmed Medical Device Science and Technology Ltd.
82%
Merxin Ltd
81%
Iconovo AB
77%

Suzhou Inhal Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 31, 2025
Series A ExtensionJun 3, 2025
Series AOct 17, 2023
Pre SeedMar 1, 2021

Key People

Founding team and executive leadership

Kaiqi Shi

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 1642% MoM, from 31 to 540.

  • Mar 1, 2021

    Completed a Pre Seed funding round.

Suzhou Inhal Pharma Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Suzhou Inhal Pharma Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Suzhou Inhal Pharma Co., Ltd.'s valuation, stock price, and market status.

Is Suzhou Inhal Pharma Co., Ltd. a public or private company?

Suzhou Inhal Pharma Co., Ltd. is a private company.

What is the current stock price of Suzhou Inhal Pharma Co., Ltd.?

Suzhou Inhal Pharma Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Suzhou Inhal Pharma Co., Ltd. worth (valuation)?

Valuation information for Suzhou Inhal Pharma Co., Ltd. is not publicly available.

Can I buy Suzhou Inhal Pharma Co., Ltd. stock?

Suzhou Inhal Pharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Suzhou Inhal Pharma Co., Ltd.'s last funding round?

Suzhou Inhal Pharma Co., Ltd.'s most recent funding round was Series B on December 31, 2025.

Who are the main investors in Suzhou Inhal Pharma Co., Ltd.?

Investor information for Suzhou Inhal Pharma Co., Ltd. is not publicly disclosed.

Will Suzhou Inhal Pharma Co., Ltd. IPO soon?

No public IPO plans have been announced for Suzhou Inhal Pharma Co., Ltd..

How can I track Suzhou Inhal Pharma Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Suzhou Inhal Pharma Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuzhou
Employee Range8
Year Founded2020
Last FundingDec 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?